Fig. (2) shows that adenoviral expression of IGFBP-5 in human skin explants ex vivo results in expression intensity and patterns comparable to those observed in SSc patient skin shown in Fig. (1). This evidence concerns the gene IGFBP5 and systemic sclerosis.